跳至主要内容
临床试验/NCT04211948
NCT04211948招募中不适用

Prospective Cohort Study Comparing Robotic and Open Surgery for Pancreatic Cancer

Ruijin Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
3 years overall survival rate

研究概览

简要总结

The purpose of this study is to determine whether robotic surgery has limitations in terms of patient age, tumor size, location, and vascular relationship when compared to open surgery for pancreatic cancer. Whether robotic surgery has advantages over intraoperative bleeding, operative time, postoperative complications (bleeding, infection, pancreatic fistula) and postoperative hospital stays compared to open surgery.And the differences in lymph nodes harvest and postoperative survival between two groups.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed pancreatic ductal adenocarcinoma
  • Patients and their families volunteered to test and signed informed consent.

排除标准

  • Preoperative exclusion:
  • Patients with metastasis (M1)
  • Patients with tumor recurrence
  • Patients with artery and/or vein invasion and can't perform radical resection and reconstruction
  • Patients with poor cardiopulmonary function cannot tolerate surgery;
  • receive neoadjuvant radiotherapy and chemotherapy before surgery;
  • The patient or family member refuses to join the group;
  • Pregnant patients
  • Intraoperative exclusion:
  • Intraoperative exploration of metastases in other parts besides the primary lesion
  • Other organs malignant tumors metastasize to the pancreas
  • Postoperative exclusion:
  • pathology confirmed non-pancreatic ductal adenocarcinoma

结局指标

主要结局

3 years overall survival rate

时间窗: 3 years post-operation

1 year overall survival rate

时间窗: 1 year post-operation

次要结局

  • Postoperative Complications(Within 90 days or before discharge)
  • 1, 3years disease free survival rate(1,3years post-operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kai Qin

Principal Investigator

Ruijin Hospital

研究点 (1)

Loading locations...

相似试验